Opko Health (OPK) Acquisitions (2010 - 2022)

Opko Health's (OPK) quarterly Acquisitions came in at $2.0 million in Q4 2022, up 186.39% on a QoQ basis from -$2.3 million in Q3 2022.

Opko Health (OPK) Acquisitions (2010 - 2022) Analysis & Trends

Opko Health (OPK) has 9 years of Acquisitions data on file, last reported at $2.0 million in Q4 2022.

Quarterly Acquisitions changed N/A year-over-year to $2.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2023 was -$313000.0 (down 108.49% YoY) and the FY2022 annual result came in at $1.8 million, down 56.05% from the prior year.
Acquisitions climbed to $2.0 million in Q4 2022, from -$2.3 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $4.0 million in Q3 2021 to a low of -$2.3 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	-
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	-
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	-
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	-
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	163.00 Mn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	-
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	2.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	-
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	225.70 Mn
10	Opko Health	1.13 Bn	824.59 Mn	80.02 Mn	-

Download Data